Literature DB >> 21416393

Literature review on the structure and operation of Pharmacy and Therapeutics Committees.

Esther Durán-García1, Bernardo Santos-Ramos, Francesc Puigventos-Latorre, Ana Ortega.   

Abstract

AIM OF THE REVIEW: To review the literature on the structure and operation of hospital Pharmacy and Therapeutics Committees from an international point of view and examine the factors that influence decision-making of these committees.
METHOD: We performed a literature search in the Medline and Embase databases from 1997 to January 2009 with the search terms: formulary system decision making, pharmacy and therapeutics committee, formularies hospital, drug formulary, survey, drug selection and outcome assessment health care. Inclusion criteria were the following: studies analyzing Pharmacy and Therapeutics Committees published in English or Spanish from 1997 to January 2009. Exclusion criteria were: publications which were editorials or opinion pieces, studies relating to one hospital, and studies where full text could not be attained. The analysis was divided into structural/organizational data and data on factors affecting the decision-making process.
RESULTS: Seventeen studies met the inclusion criteria. Pharmacy and Therapeutics Committees and formularies were present in more than 90% of the hospitals in four of the five countries examined. Therapeutic interchange programs existed only in two of these countries. The mean number of committee members ranged between six and eight. More than 89% of the committees included a pharmacist. Standard operating procedures were implemented by 89% of the committees. The most influential factors in the decision-making were clinical trial results or drug costs rather than pharmacoeconomic studies. Other local organization-dependent factors were also important.
CONCLUSIONS: The structure and operating procedures of Hospital Pharmacy and Therapeutics Committees are similar in select Western countries. Information from clinical trials is the most influential factor in the decision-making process.

Mesh:

Year:  2011        PMID: 21416393     DOI: 10.1007/s11096-011-9501-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


  29 in total

1.  Pharmacy and therapeutics committee 'virtual' meetings.

Authors:  C Devenport
Journal:  Am J Health Syst Pharm       Date:  1999-06-01       Impact factor: 2.637

2.  Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.

Authors:  A Anell; P Svarvar
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

Review 3.  Disappointing biotech.

Authors:  Roberta Joppi; Vittorio Bertele'; Silvio Garattini
Journal:  BMJ       Date:  2005-10-15

4.  Survey of hospital pharmacy practice in Flemish-speaking Belgium.

Authors:  Ludo Willems; Albert Raymakers; Walter Sermeus; Arthur Vleugels; Gert Laekeman
Journal:  Am J Health Syst Pharm       Date:  2005-02-01       Impact factor: 2.637

5.  Formulary management as a tool to improve medication use and gain physician support.

Authors:  David F Lehmann; Roy Guharoy; Nancy Page; Karen Hirschman; Robert Ploutz-Snyder; Joseph Medicis
Journal:  Am J Health Syst Pharm       Date:  2007-03-01       Impact factor: 2.637

6.  ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2007.

Authors:  Craig A Pedersen; Philip J Schneider; Douglas J Scheckelhoff
Journal:  Am J Health Syst Pharm       Date:  2008-05-01       Impact factor: 2.637

7.  Structure and activities of hospital drug committees in Germany.

Authors:  P A Thürmann; S Harder; A Steioff
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

8.  ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.

Authors:  C A Pedersen; P J Schneider; J P Santell
Journal:  Am J Health Syst Pharm       Date:  2001-12-01       Impact factor: 2.637

9.  Use of pharmacoeconomic data in making hospital formulary decisions.

Authors:  Folakemi T Odedina; Johanna Sullivan; Rowena Nash; C Denise Clemmons
Journal:  Am J Health Syst Pharm       Date:  2002-08-01       Impact factor: 2.637

10.  Developing the role of the drug and therapeutics committees: perceptions of chairs.

Authors:  Ingeborg K Björkman; Ingrid K Schmidt; Inger Holmström; Cecilia B Bernsten
Journal:  Int J Health Care Qual Assur       Date:  2007
View more
  17 in total

1.  Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark.

Authors:  Hanne T Plet; Jesper Hallas; Lene J Kjeldsen
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

2.  Do educational meetings and group detailing change adherence to drug formularies in hospitals? A cluster randomized controlled trial.

Authors:  Hanne T Plet; Lene J Kjeldsen; René de Pont Christensen; Gitte S Nielsen; Jesper Hallas
Journal:  Eur J Clin Pharmacol       Date:  2014-01       Impact factor: 2.953

3.  Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.

Authors:  Jaime E Vargas-Rivas; Daniel Sabater-Hernández; Miguel A Calleja-Hernández; María J Faus; Fernando Martínez-Martínez
Journal:  Int J Clin Pharm       Date:  2011-08-17

4.  The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income country.

Authors:  Israel Rico-Alba; Albert Figueras
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

5.  Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network.

Authors:  Natasha Burke; James M Bowen; Sue Troyan; Jathishinie Jegathisawaran; Carolyn Gosse; Marita Tonkin; Sandra Kagoma; Ron Goeree; Anne Holbrook
Journal:  Can J Hosp Pharm       Date:  2016-06-30

6.  Factors associated with prescribing restriction on oncology formulary drugs in Malaysia.

Authors:  Omotayo Fatokun; Michael N Olawepo
Journal:  Int J Clin Pharm       Date:  2016-09-01

7.  A P&T Committee's Transition to a Complete Electronic Meeting System-A Multisite Institution Experience.

Authors:  Ahmed H Al-Jedai; Roaa A Algain; Said A Alghamidi; Abdulrazaq S Al-Jazairi; Rashid Amin; Ibrahim Z Bin Hussain
Journal:  P T       Date:  2017-10

8.  Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.

Authors:  Ken LaPensee; Thomas Lodise
Journal:  Am Health Drug Benefits       Date:  2018-12

9.  A prescription for improving drug formulary decision making.

Authors:  Gordon D Schiff; William L Galanter; Jay Duhig; Michael J Koronkowski; Amy E Lodolce; Pam Pontikes; John Busker; Daniel Touchette; Surrey Walton; Bruce L Lambert
Journal:  PLoS Med       Date:  2012-05-22       Impact factor: 11.069

10.  The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.

Authors:  Mikael Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.